Management of Stage 2 Hypertension in a 78-Year-Old Woman
This patient requires immediate initiation of combination antihypertensive therapy with two first-line agents, targeting a blood pressure of 120-129/70-79 mmHg, while her scheduled pain injections can proceed once blood pressure is adequately controlled.
Immediate Blood Pressure Management
Classification and Urgency
- Blood pressure of 180/93 mmHg represents Stage 2 hypertension requiring prompt treatment 1
- This is not a hypertensive emergency (BP <220/110 mmHg without acute end-organ damage), so oral therapy is appropriate rather than IV medications 1
- The patient should be evaluated and treatment initiated within 1 month, with reassessment in 1 month after starting therapy 1
Initial Pharmacological Approach
Start combination therapy immediately with two agents from different classes 1:
- Preferred combination: RAS blocker (ACE inhibitor or ARB) + calcium channel blocker (CCB) 1
- Alternative combination: RAS blocker + thiazide-like diuretic (chlorthalidone or indapamide) 1
- Use a single-pill combination to improve adherence 1, 2
Specific regimen examples 3:
- Amlodipine 5mg + lisinopril 10mg once daily, OR
- Amlodipine 5mg + losartan 50mg once daily, OR
- Chlorthalidone 12.5mg + lisinopril 10mg once daily
Target Blood Pressure
Aim for systolic BP 120-129 mmHg and diastolic BP 70-79 mmHg 1, 2:
- This target applies to patients up to age 85 years if treatment is well tolerated 1, 2
- At age 78, she is not in the ≥85 year category where more conservative targets might apply 1
- If she cannot tolerate this target due to symptoms, follow the "as low as reasonably achievable" (ALARA) principle 1, 2
Escalation Strategy if Initial Therapy Inadequate
Step 3: Triple Therapy
If BP remains uncontrolled after 2-4 weeks on dual therapy, escalate to triple combination 1, 2:
Step 4: Resistant Hypertension
If BP remains ≥140/90 mmHg on optimal doses of three drugs 1:
- Add low-dose spironolactone 25mg once daily (if serum potassium <4.6 mmol/L) 1
- Check electrolytes and renal function within 1 month 1
- If spironolactone not tolerated: consider eplerenone, beta-blocker (bisoprolol), or alpha-blocker (doxazosin) 1
Special Considerations for Elderly Patients
Orthostatic Hypotension Monitoring
Measure both sitting and standing blood pressures at each visit 2, 4:
- Elderly patients have reduced baroreflex sensitivity increasing vulnerability to orthostatic hypotension 4
- Standing BP measurements should guide treatment decisions 1
- Symptomatic orthostatic hypotension may require dose adjustment 1
Titration Approach
- Start with lower doses and titrate more slowly than in younger patients 4, 5
- Monitor for cognitive impairment, falls, and electrolyte abnormalities 4, 5
- Reassess within 2-4 weeks after medication changes 2
Pain Management and Scheduled Injections
Proceeding with Pain Injections
The scheduled pain injections for scoliosis-related chronic pain can proceed once BP is controlled to <180/110 mmHg 1:
- There is no absolute contraindication to epidural or facet injections at current BP level 1
- However, better BP control reduces perioperative cardiovascular risk 1
- Ideally, achieve BP <140/90 mmHg before elective procedures 1
Pain Management Considerations
- Epidural steroid injections and facet injections provide short-term pain relief (2 weeks to 2 months) for chronic back pain from degenerative disease 1
- NSAIDs used for pain management may interfere with BP control and should be avoided or minimized 3
- Acetaminophen is preferred for pain management in hypertensive patients 3
Lifestyle Modifications (Concurrent with Medications)
Initiate immediately alongside pharmacotherapy 1, 3:
- Sodium restriction to <2g/day (most important for elderly patients) 1
- DASH diet or Mediterranean diet pattern 1, 3
- Potassium supplementation if not contraindicated by renal function 3
- Weight loss if BMI >25 kg/m² 1
- Limit alcohol to <100g/week 1
- Regular physical activity as tolerated given scoliosis 1
Monitoring Plan
Follow-up Schedule
- Recheck BP in 1 month after initiating therapy 1, 2
- Measure electrolytes and renal function 2-4 weeks after starting RAS blocker or diuretic 1, 2
- Aim to achieve target BP within 3 months 2
- Consider home BP monitoring to assess treatment efficacy 2
Common Pitfalls to Avoid
- Therapeutic inertia: Failing to intensify treatment when BP remains uncontrolled is the most common error 2
- Starting with monotherapy in Stage 2 hypertension delays BP control 1
- Using twice-daily dosing regimens that reduce adherence 2
- Failing to check standing BP in elderly patients 2, 4
- Delaying necessary procedures indefinitely due to hypertension when BP is not severely elevated 1
- Combining two RAS blockers (ACE inhibitor + ARB), which is contraindicated 1